Acorda Therapeutics SG&A Expense (Quarterly) Insights

Acorda Therapeutics Inc (ACORQ)

0.605 +0.10 (+18.63%) USD | OTCM | May 17, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2003. Upgrade now.

Date	Value
March 31, 2024	28.37M
December 31, 2023	22.21M
September 30, 2023	23.15M
June 30, 2023	21.82M
March 31, 2023	22.51M
December 31, 2022	26.25M
September 30, 2022	23.00M
June 30, 2022	30.07M
March 31, 2022	26.94M
December 31, 2021	28.44M
September 30, 2021	29.62M
June 30, 2021	32.37M
March 31, 2021	33.97M
December 31, 2020	32.88M
September 30, 2020	39.94M
June 30, 2020	38.66M
March 31, 2020	41.11M
December 31, 2019	41.22M
September 30, 2019	48.70M
June 30, 2019	50.20M
March 31, 2019	52.72M
December 31, 2018	36.82M
September 30, 2018	43.57M
June 30, 2018	44.26M
March 31, 2018	47.60M

Date	Value
December 31, 2017	39.52M
September 30, 2017	40.74M
June 30, 2017	49.33M
March 31, 2017	52.02M
December 31, 2016	59.05M
September 30, 2016	54.80M
June 30, 2016	62.60M
March 31, 2016	58.98M
December 31, 2015	52.98M
September 30, 2015	51.06M
June 30, 2015	52.82M
March 31, 2015	48.77M
December 31, 2014	56.46M
September 30, 2014	47.82M
June 30, 2014	50.64M
March 31, 2014	46.89M
December 31, 2013	47.01M
September 30, 2013	42.34M
June 30, 2013	48.00M
March 31, 2013	48.20M
December 31, 2012	45.59M
September 30, 2012	40.12M
June 30, 2012	44.23M
March 31, 2012	38.74M
December 31, 2011	35.72M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

21.82M

Minimum

Jun 2023

50.20M

Maximum

Jun 2019

32.07M

Average

29.84M

Median

SG&A Expense (Quarterly) Benchmarks